Kristian Brock

Kristian Brock

Links

ORCID: 0000-0002-3921-0166

Colleges, School and Institutes

View graph of relations

Most downloaded publications

How to design a dose-finding study using the continual reassessment method
Kristian Brock, Christina Yap, 18 Jan 2019, In : BMC Medical Research Methodology. 19, 1, 15 p., 18.

Research output: Contribution to journal › Article

121 downloads
Combination Lenalidomide and Azacitidine: A Novel Salvage Therapy in Patients Who Relapse After Allogeneic Stem-Cell Transplantation for Acute Myeloid Leukemia
Charles Craddock, Daniel Slade, Carmela De Santo, Rachel Hoare, Kristian Brock, Francis Mussai & Christina Yap, 1 Mar 2019, In : Journal of Clinical Oncology . 37, 7, p. 580-588 9 p., JCO1800889.

Research output: Contribution to journal › Article

117 downloads
Acquired Isodisomy on Chromosome 13 at diagnosis results in impaired overall survival in Patients with FLT3-ITD mutant Acute Myeloid Leukaemia
Justin Loke, Kristian Brock, Paul Ferguson, Charles Craddock & Manoj Raghavan, 2015, In : Leukemia. 29, 12, p. 2404-2407

Research output: Contribution to journal › Article

109 downloads
Recommendations for Randomised Trials in Surgical Oncology
James Glasbey, Kristian Brock & Simon Bach, Dec 2017, In : Clinical Oncology. 29, 12, p. 799-810

Research output: Contribution to journal › Article

90 downloads
Sustained release of decorin to the surface of the eye enables scarless corneal regeneration
Lisa J Hill, Richard Moakes, Gibran Butt, Kristian Brock, Rachel Vincent, Richard Williams, Nicholas Barnes, Graham Wallace, Saaeha Rauz, Ann Logan & Liam Grover, 21 Dec 2018, In : npj Regenerative Medicine. 3, 12 p., 23.

Research output: Contribution to journal › Article

86 downloads

Recent publications

Pembrolizumab in patients with non-small-cell lung cancer of performance status 2 (PePS2): a single arm, phase 2 trial
Gary Middleton, Kristian Brock & Cindy Billingham, 19 Mar 2020, In : The Lancet Respiratory Medicine.

Research output: Contribution to journal › Article

CSTI-300 (SMP-100); a novel 5-HT3 receptor partial agonist with potential to treat patients with irritable bowel syndrome or carcinoid syndrome
Alexander Roberts, Gillian Grafton, Andy Powell, Kristian Brock, Alison Cooper, Omar Qureshi, Zania Stamataki & Nicholas Barnes, 24 Jan 2020, (Accepted/In press) In : Journal of Pharmacology and Experimental Therapeutics.

Research output: Contribution to journal › Article

A Phase II Clinical Trial with Efficacy and Toxicity Outcomes and Baseline Covariates
Kristian Brock, Cindy Billingham, Christina Yap & Gary Middleton, 27 Nov 2019, Bayesian Statistics: New Challenges and New Generations. Springer, p. 125-133 (Springer Proceedings in Mathematics & Statistics; vol. 296).

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution

View all (22)

Recent Activities

Dose-Finding Clinical Trial Designs in Stan
Kristian Brock (Speaker)
30 Aug 2018

Activity: Talk or presentation › Academic conference

A Phase II Clinical Trial with Efficacy and Toxicity Outcomes and Baseline Covariates
Kristian Brock (Speaker), Cindy Billingham (Contributor), Gary Middleton (Contributor), Christina Yap (Contributor)
2 Jul 2018

Activity: Talk or presentation › Academic conference

Benefits and limitations of subgroup analyses in oncology trials
Kristian Brock (Invited speaker)
4 May 2018

Activity: Talk or presentation › Invited talk

View all (21)